Aadi Bioscience, Inc. (AADI)
NASDAQ: AADI · Real-Time Price · USD
2.290
+0.070 (3.15%)
Nov 21, 2024, 3:00 PM EST - Market open
Aadi Bioscience Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Net Income | -61.69 | -65.77 | -60.51 | -110.09 | -3.48 | -12.26 |
| Depreciation & Amortization | 0.19 | 0.17 | 0.16 | 0.11 | 0.01 | 0.01 |
| Asset Writedown & Restructuring Costs | - | - | 3.72 | 74.16 | - | - |
| Loss (Gain) From Sale of Investments | -1.6 | -3.14 | -1.22 | - | - | - |
| Stock-Based Compensation | 12.1 | 11.95 | 9.64 | 2.11 | 0.14 | 0.11 |
| Other Operating Activities | 0.5 | 0.52 | 0.38 | -0.95 | 1.14 | 0.2 |
| Change in Accounts Receivable | -0.82 | -3.63 | -1.86 | 14.15 | -13.86 | -0.04 |
| Change in Inventory | -1.27 | -3.27 | -1.86 | - | - | - |
| Change in Accounts Payable | -5.55 | -0.13 | 3.22 | 8.29 | 1.08 | 3.24 |
| Change in Other Net Operating Assets | 4.01 | 3.62 | -1.32 | -10.19 | 2.28 | 1.16 |
| Operating Cash Flow | -54.14 | -59.66 | -49.64 | -22.42 | -12.7 | -7.58 |
| Capital Expenditures | -2.28 | -3.97 | -0.44 | -0.05 | - | -0.04 |
| Cash Acquisitions | - | - | - | 25.2 | - | - |
| Investment in Securities | 18 | 87.18 | -132.44 | - | - | - |
| Investing Cash Flow | 15.72 | 83.21 | -132.89 | 25.15 | - | -0.04 |
| Long-Term Debt Issued | - | - | - | - | 1.19 | 8.08 |
| Net Debt Issued (Repaid) | - | - | - | - | 1.19 | 8.08 |
| Issuance of Common Stock | 0.21 | 0.49 | 73.28 | 155.83 | - | - |
| Preferred Dividends Paid | - | - | - | -4.41 | - | - |
| Dividends Paid | - | - | - | -4.41 | - | - |
| Other Financing Activities | -0.05 | -0.16 | -0.66 | -9.62 | - | - |
| Financing Cash Flow | 0.16 | 0.33 | 72.62 | 141.8 | 1.19 | 8.08 |
| Net Cash Flow | -38.27 | 23.87 | -109.91 | 144.53 | -11.51 | 0.46 |
| Free Cash Flow | -56.43 | -63.64 | -50.08 | -22.47 | -12.7 | -7.62 |
| Free Cash Flow Margin | -225.07% | -261.29% | -329.15% | -2006.16% | -87.11% | -1017.33% |
| Free Cash Flow Per Share | -2.09 | -2.36 | -2.22 | -2.52 | -5.00 | -0.95 |
| Cash Interest Paid | 0.23 | 0.23 | 0.23 | - | - | - |
| Cash Income Tax Paid | - | - | - | - | - | 0 |
| Levered Free Cash Flow | -35.62 | -37.7 | -29.52 | -15.23 | -12.2 | - |
| Unlevered Free Cash Flow | -35.49 | -37.56 | -29.38 | -14.81 | -11.69 | - |
| Change in Net Working Capital | 5.75 | 0.75 | 1.89 | -6.19 | 10.25 | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.